StreetAlpha.app
Home › Stocks › MEDP

Medpace Holdings, Inc. (MEDP)

Healthcare
$653.09
▲ +0.75%
LAST CLOSE · NOV 17

Medpace provides outsourced clinical trial services to drug, biologic and medical device developers. It last closed at $653.09 on Nov 17, up 0.75% on the day. MEDP reports earnings on Mon, Feb 8, 2027. The average 12-month price target from 6 analysts is $675.17 (+3.4% from the last close), with a high of $700.00 and a low of $633.00. Analyst consensus is Hold, based on the latest ratings from 6 firms (1 buy, 5 hold, 0 sell). Over the past 90 days StreetAlpha recorded 2 whale options trades in MEDP, 100% of them bullish and 0% bearish. In the past 30 days there were 3 dark pool prints totaling $3.2M, the largest $1.4M.

AI Auto Pilots
Is MEDP in one of our four AI portfolios? Sign in free to see

Key Stats

Last 12 months
Results
Revenue
$2.8B
+20.4% vs a year ago
Net income
$517.8M
+19.6% vs a year ago
EPS (diluted)
$18.01
+25.9% vs a year ago
Free cash flow
$667.6M
23.5% margin
Valuation
Market cap
$18.3B
28.0M shares
P/E
36.3
Price over 12 month EPS
Price to sales
6.4
Market cap over revenue
Dividend yield
None
No dividend in 12 months
Balance sheet
Cash & equivalents
$705.3M
At Sep 30
Shareholder equity
$584.9M
Buybacks
$294.8M
Last 12 months
Fiscal year endsDecember
ExchangeNasdaq
Financials history
FY2021: $1.1B$1.1BFY2021FY2022: $1.5B$1.5BFY2022FY2023: $1.9B$1.9BFY2023FY2024: $2.1B$2.1BFY2024FY2025: $2.5B$2.5BFY2025

From MEDP's SEC filings, latest 10-Q for the period ending Sep 30, 2026 (filed Oct 22). Last 12 months adds up the four latest quarters.

Next report
Feb 8
2027 · Time not announced
Consensus EPS forecast
$4.82
$718.4M revenue est.
Year-ago EPS
—
Not on file
Options-implied move
—
Posted about a week before
Analyst consensus
Hold
Based on 6 analyst ratings (90 days)
Loading…

Analyst Ratings & Price Targets

Analyst Ratings →
Consensus · 90 days
Hold
6firms
1 Buy5 Hold0 Sell
Each firm's latest rating on MEDP in the past 90 days
Average 12-month target
$675.17
▲ 3.4% upside

Based on 6 analysts who set a price target on MEDP in the past 90 days. The average target is $675.17, with a high of $700.00 and a low of $633.00, compared with the last close of $653.09.

Low $633.00Avg $675.17High $700.00
Blue marker: last close $653.09
Highest target$700.00
Average target$675.17
Lowest target$633.00
Latest rating changes
BMO CapitalTarget raised
Oct 26Hold$600 → $670
UBSTarget raised
Oct 23Hold$673 → $700
Truist SecuritiesTarget raised
Oct 23Hold$609 → $633
BarclaysTarget raised
Oct 23Hold$625 → $675
TD CowenTarget raised
Oct 23Hold$492 → $673
DateFirmActionRatingPrice target
Oct 26BMO CapitalTarget raisedHold$600 → $670
Oct 23UBSTarget raisedHold$673 → $700
Oct 23Truist SecuritiesTarget raisedHold$609 → $633
Oct 23BarclaysTarget raisedHold$625 → $675
Oct 23TD CowenTarget raisedHold$492 → $673
Loading…

Technical Analysis

MEDP · as of the Nov 17 close · updated after every close
Uptrend

The stock sits between its 20 and 50 day averages. It is 18% above its 200 day average, so the longer trend is still up. Momentum is fading (RSI 52). The nearest support is the Pivot at $648.65, and the nearest resistance the Pivot R1 at $658.10.

Short trendBullish
Long trendBullish
MomentumFading
StretchNormal
VolatilityNormal, 3.0%/day
Key levels
$693.9752 week high+6.3%
$677.90Swing high (Jul 23)+3.8%
$661.4620 day average+1.3%
$658.10Pivot R1+0.8%
$653.09Last close
$648.65Pivot−0.7%
$643.65Pivot S1−1.4%
$631.9050 day average−3.2%
$631.73Swing low (Nov 5)−3.3%
$603.62100 day average−7.6%
$532.67200 day average−18.4%
$373.0052 week low−42.9%
Indicators
RSI (14)51.74Middle of its rangeNeutral
MACD6.51Below its signal lineBearish
Stochastic32.9Middle of its rangeNeutral
ADX (14)28.6Trending up
Williams %R-63.3Oversold below −80, overbought above −20Neutral
CCI (20)-86.5Oversold below −100, overbought above 100Neutral
Rate of change−1.6%Change over 10 sessionsBearish
ATR (14)$19.39Typical daily range, 3.0% of price
MA 10Below
MA 20Below
MA 50Above
MA 100Above
MA 200Above
What happened before, for MEDP

What happened before

See how MEDP did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record.

November seasonalityHow MEDP usually does this month. See Seasonality

Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.

Seasonality

How MEDP has done in each calendar month: the average and median return, how often each month finished higher, and every year since 2016.

Loading…

See the stocks that usually rise in November →

Whale Options Flow

90D
Total alerts
2
Bullish
2
100%
Bearish
0
0%
Date span
Sep 23 – Oct 5
Loading…

See today’s whale options flow across the market →

Dark Pool

30D
Prints
3
Notional
$3.2M
Largest print
$1.4M
Loading…

MEDP Institutional Ownership

Full report →
Fund sentiment · Q3 2026
Bullish
Strongly bearishNeutralStrongly bullish
  • ▲373 buying vs 316 selling
  • ▼Held by funds -6.2 pts
  • ▲Funds holding +53
  • ▲Superinvestors: 5 added, 1 cut
  • ●Put/call not meaningful
Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Funds holdingHeld by funds %
Q3 2026This quarterLast quarterChange
Funds holding755702+7.5%
In funds' top 1065+20.0%
Held by funds82.5%88.7%−6.2 pts
New / increased127 / 24667 / 206+36.6%
Reduced / sold out255 / 61309 / 104−23.5%
Put/call ratio6.660.91+632.2%
Top holders, biggest buyers and sellers, 8 quarters of charts and this season's filings so far.See MEDP institutional ownership →

From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.

AI Auto Pilots

Paper trading

StreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether MEDP is in one of them and how their past MEDP trades turned out.

MEDP in the AI portfolios
Loading…

Macro & Market News

All StreetAlpha news →

StreetAlpha hasn't covered MEDP in an article yet. Here's the latest on the wider market.

MEDP Congress Trades

All congress trades →
Trades, 12 months
8
Buys
4
50%
Sells
4
50%
People
3
Last filed May 28
Who traded MEDP · since 2020
Latest 5 filings of 25
$1K – $15KTraded May 15, 2026Filed May 28, 2026
$1K – $15KTraded May 15, 2026Filed May 28, 2026
$1K – $15KTraded Jan 30, 2026Filed Apr 10, 2026
$1K – $15KTraded Feb 26, 2026Filed Mar 6, 2026
$15K – $50KTraded Jan 15, 2026Filed Feb 13, 2026
PersonTypeAmountTradedFiledDelay
David TaylorR · OHBuy$1K – $15KMay 15, 2026May 28, 202613 d
David TaylorR · OHBuy$1K – $15KMay 15, 2026May 28, 202613 d
Arjun ModyExecutive branchSell$1K – $15KJan 30, 2026Apr 10, 202670 d
David TaylorR · OHBuy$1K – $15KFeb 26, 2026Mar 6, 20268 d
Gilbert CisnerosD · CASell$15K – $50KJan 15, 2026Feb 13, 202629 d

Members of Congress and senior officials report trades up to 45 days later, as dollar ranges. Filings show a trade happened, not why. Not investment advice.

About Medpace Holdings

Medpace is a contract research organization that runs clinical trials for drug, biologic and medical device developers. It provides services across the full clinical development process, from early Phase I testing through Phase IV, including study management, patient recruitment, monitoring, regulatory affairs, biometrics, safety reporting, and laboratory testing. Its customers include small, midsize and large biopharmaceutical and pharmaceutical companies. The company is based in Cincinnati, Ohio.

Headquarters
Cincinnati, OH